Analysts at Leerink Partnrs decreased their Q1 2025 earnings estimates for shares of 10x Genomics in a research note issued to investors on Thursday, February 13th. Leerink Partnrs analyst P. Souda ...

PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

This is a jointly funded 1 FTE role: 0.75 FTE with Flinders University and 0.25 FTE with South Australian Genomics Centre (SAGC), which is based at the South Australian Health and Medical Research ...

Potential anti-tumor therapies remain to be discovered in cancer cell line high-throughput screening datasets. Here, the authors develop a machine learning approach to infer cancer cell drug ...